Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk?-Reference-Cited by-同舟云学术

Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk?

Published:2009-12-15 Issue:7 Volume:53 Page:1332-1333
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Paulino Arnold C.,Pappo Alberto

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference5 articles.

1. Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: A preliminary report from the Intergroup Rhabdomyosarcoma Study-IV (1991-1997);Neville;J Pediatr Surg,2000

2. Results of intensive therapy in children with localized alveolar extremity rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study;Heyn;J Clin Oncol,1989

3. Childrens Oncology Group Protocol D9803, Randomized Study of Vincristine, Actinomycin-D, and Cyclophosphamide (VAC) versus VAC alternating with Vincristine, Topotecan and Cyclophosphamide for Patients with Intermediate-Risk Rhabdomyosarcoma.

4. Anatomy of the human body

5. Outcome for children with Group III rhabdomyosarcoma treated with or without radiotherapy;Viswanathan;Int J Radiat Oncol Biol Phys,2004

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In transit metastases in children, adolescents and young adults with localized rhabdomyosarcoma of the distal extremities: Analysis of the EpSSG RMS 2005 study;European Journal of Surgical Oncology;2022-07

2. Angiogenesis and immune checkpoint dual blockade in combination with radiotherapy for treatment of solid cancers: opportunities and challenges;Oncogenesis;2021-07

3. Pattern of relapse in pediatric localized extremity rhabdomyosarcomas correlated with locoregional therapies administered;Strahlentherapie und Onkologie;2021-04-29

4. Use of Antiangiogenic Therapies in Pediatric Solid Tumors;Cancers;2021-01-12

5. Fusion status in patients with lymph node‐positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG);Cancer;2018-05-24